Cartesian Therapeutics In... (RNAC)
17.58
-1.26 (-6.69%)
At close: Mar 03, 2025, 3:59 PM
17.50
-0.46%
After-hours: Mar 03, 2025, 04:00 PM EST
Cartesian Therapeutics Cash Flow Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
Net Income | -219.71M | 35.38M | -25.69M | -68.88M | -55.35M | -65.34M | -65.32M | -36.21M | -25.17M | -12.88M |
Depreciation & Amortization | 1.55M | 1.29M | 1.25M | 734K | 2.03M | 975K | 750K | 802K | 1.04M | 864K |
Stock-Based Compensation | 22.52M | 11.19M | 7.72M | 5.42M | n/a | n/a | n/a | n/a | n/a | 1.22M |
Other Working Capital | 1.23M | -64.71M | -45.5M | 94.46M | 1.12M | -265K | 9.3M | 9.91M | -87K | -1.48M |
Other Non-Cash Items | 158.5M | 2.29M | 2.13M | 1.75M | 16.02M | 8.45M | 9.09M | 830K | 2.81M | 193K |
Deferred Income Tax | -19M | -21.4M | 2.4M | 10.85M | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 4.97M | -60.38M | -48.19M | 85M | -4.48M | -781K | 7.12M | 13.2M | 427K | -2.09M |
Operating Cash Flow | -51.16M | -31.63M | -60.38M | 34.88M | -51.44M | -59.16M | -52.04M | -19.68M | -22.46M | -12.69M |
Capital Expenditures | -206K | -1.2M | -1.08M | -815K | -47K | -884K | -733K | -586K | -1.16M | -227K |
Acquisitions | 6.56M | n/a | n/a | 74K | 122K | 99K | 4K | 2K | n/a | n/a |
Purchase of Investments | n/a | -33.5M | -32.45M | n/a | -18.19M | -15.6M | -61.53M | -28.42M | n/a | n/a |
Sales Maturities Of Investments | 28.25M | 19.7M | 16.4M | n/a | 18.34M | 41.66M | 60.16M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.9M | -3.52M | n/a |
Investing Cash Flow | 34.61M | -15M | -17.14M | -741K | 229K | 25.27M | -2.1M | -22.1M | -4.68M | -227K |
Debt Repayment | -27.46M | n/a | n/a | 5.42M | -2.8M | n/a | 8.02M | n/a | 11.43M | 4.49M |
Common Stock Repurchased | -6.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 20.48M | 235K | 939K | -3.37M | 70.18M | 697K | 886K | -3.95M | 32.37M | 20.28M |
Financial Cash Flow | -13.14M | 39.22M | 52.9M | 14.43M | 105.04M | 697K | 66.02M | 67.66M | 43.91M | 24.77M |
Net Cash Flow | -29.75M | -7.4M | -24.63M | 48.51M | 52.77M | -33.3M | 11.96M | 25.88M | 16.76M | 8.54M |
Free Cash Flow | -51.37M | -32.83M | -61.47M | 34.07M | -51.48M | -60.05M | -52.77M | -20.27M | -23.63M | -12.91M |